94 related articles for article (PubMed ID: 32220305)
1. Safety, Tumor Reduction, and Clinical Impact of Zika Virus Injection in Dogs with Advanced-Stage Brain Tumors.
Kaid C; Madi RADS; Astray R; Goulart E; Caires-Junior LC; Mitsugi TG; Moreno ACR; Castro-Amarante MF; Pereira LR; Porchia BFMM; de Andrade TO; Landini V; Sanches DS; Pires CG; Tanioka RKO; Pereira MCL; Barbosa IN; Massoco CO; Ferreira LCS; Okamoto OK; Zatz M
Mol Ther; 2020 May; 28(5):1276-1286. PubMed ID: 32220305
[TBL] [Abstract][Full Text] [Related]
2. The Oncolytic Activity of Zika Viral Therapy in Human Neuroblastoma In Vivo Models Confers a Major Survival Advantage in a CD24-dependent Manner.
Mazar J; Brooks JK; Peloquin M; Rosario R; Sutton E; Longo M; Drehner D; Westmoreland TJ
Cancer Res Commun; 2024 Jan; 4(1):65-80. PubMed ID: 38214542
[TBL] [Abstract][Full Text] [Related]
3. Oncolytic Sendai Virus Therapy of Canine Mast Cell Tumors (A Pilot Study).
Ilyinskaya GV; Mukhina EV; Soboleva AV; Matveeva OV; Chumakov PM
Front Vet Sci; 2018; 5():116. PubMed ID: 29915788
[No Abstract] [Full Text] [Related]
4. Reply to "Questioning the Use of Zika Virus Injection in Dogs with Advanced-Stage Brain Tumors".
Kaid C; Zatz M
Mol Ther; 2021 Jan; 29(1):6-7. PubMed ID: 33321096
[No Abstract] [Full Text] [Related]
5. Questioning the Use of Zika Virus Injection in Dogs with Advanced-Stage Brain Tumors.
Morrison K; Parmentier T; Bienzle D
Mol Ther; 2021 Jan; 29(1):4-6. PubMed ID: 33333008
[No Abstract] [Full Text] [Related]
6. Effect of Serial Systemic and Intratumoral Injections of Oncolytic ZIKV
Ferreira RO; Granha I; Ferreira RS; Bueno HS; Okamoto OK; Kaid C; Zatz M
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696533
[TBL] [Abstract][Full Text] [Related]
7. Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade.
Nair S; Mazzoccoli L; Jash A; Govero J; Bais SS; Hu T; Fontes-Garfias CR; Shan C; Okada H; Shresta S; Rich JN; Shi PY; Diamond MS; Chheda MG
JCI Insight; 2021 Jan; 6(1):. PubMed ID: 33232299
[TBL] [Abstract][Full Text] [Related]
8. Zika virus-based immunotherapy enhances long-term survival of rodents with brain tumors through upregulation of memory T-cells.
Crane AT; Chrostek MR; Krishna VD; Shiao M; Toman NG; Pearce CM; Tran SK; Sipe CJ; Guo W; Voth JP; Vaid S; Xie H; Lu WC; Swanson W; Grande AW; Schleiss MR; Bierle CJ; Cheeran MC; Low WC
PLoS One; 2020; 15(10):e0232858. PubMed ID: 33002018
[TBL] [Abstract][Full Text] [Related]
9. Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial.
Fares J; Ahmed AU; Ulasov IV; Sonabend AM; Miska J; Lee-Chang C; Balyasnikova IV; Chandler JP; Portnow J; Tate MC; Kumthekar P; Lukas RV; Grimm SA; Adams AK; Hébert CD; Strong TV; Amidei C; Arrieta VA; Zannikou M; Horbinski C; Zhang H; Burdett KB; Curiel DT; Sachdev S; Aboody KS; Stupp R; Lesniak MS
Lancet Oncol; 2021 Aug; 22(8):1103-1114. PubMed ID: 34214495
[TBL] [Abstract][Full Text] [Related]
10. Recent oncolytic virotherapy clinical trials outline a roadmap for the treatment of high-grade glioma.
Bernstock JD; Blitz SE; Hoffman SE; Gerstl JVE; Chiocca EA; Friedman GK
Neurooncol Adv; 2023; 5(1):vdad081. PubMed ID: 37497017
[TBL] [Abstract][Full Text] [Related]
11. Oncolytic Zika virus promotes intratumoral T cell infiltration and improves immunotherapy efficacy in glioblastoma.
Chen L; Zhou C; Chen Q; Shang J; Liu Z; Guo Y; Li C; Wang H; Ye Q; Li X; Zu S; Li F; Xia Q; Zhou T; Li A; Wang C; Chen Y; Wu A; Qin C; Man J
Mol Ther Oncolytics; 2022 Mar; 24():522-534. PubMed ID: 35229030
[TBL] [Abstract][Full Text] [Related]
12. Zika Virus: A Neurotropic Warrior against High-Grade Gliomas-Unveiling Its Potential for Oncolytic Virotherapy.
Calderón-Peláez MA; Maradei Anaya SJ; Bedoya-Rodríguez IJ; González-Ipuz KG; Vera-Palacios D; Buitrago IV; Castellanos JE; Velandia-Romero ML
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675903
[TBL] [Abstract][Full Text] [Related]
13. Oncolytic Newcastle disease virus induced degradation of YAP through E3 ubiquitin ligase PRKN to exacerbate ferroptosis in tumor cells.
Sun Y; Tang L; Kan X; Tan L; Song C; Qiu X; Liao Y; Nair V; Ding C; Liu X; Sun Y
J Virol; 2024 Mar; 98(3):e0189723. PubMed ID: 38411946
[TBL] [Abstract][Full Text] [Related]
14. Repurposing of Zika virus live-attenuated vaccine (ZIKV-LAV) strains as oncolytic viruses targeting human glioblastoma multiforme cells.
Victorio CBL; Novera W; Ganasarajah A; Ong J; Thomas M; Wu J; Toh HSY; Sun AX; Ooi EE; Chacko AM
J Transl Med; 2024 Feb; 22(1):126. PubMed ID: 38308299
[TBL] [Abstract][Full Text] [Related]
15. Genetically modified ZIKA virus as a microRNA-sensitive oncolytic virus against central nervous system tumors.
Novaes GM; Lima C; Longo C; Machado PH; Silva TP; Olberg GGO; Módolo DG; Pereira MCL; Santos TG; Zatz M; Lagares D; de Franco M; Ho PL; Bulstrode H; Okamoto OK; Kaid C
Mol Ther; 2024 Feb; 32(2):440-456. PubMed ID: 38213031
[TBL] [Abstract][Full Text] [Related]
16. Flaviviruses in AntiTumor Therapy.
Nazarenko AS; Vorovitch MF; Biryukova YK; Pestov NB; Orlova EA; Barlev NA; Kolyasnikova NM; Ishmukhametov AA
Viruses; 2023 Sep; 15(10):. PubMed ID: 37896752
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor activity of a recombinant measles virus against canine lung cancer cells.
Tamura K; Fujiyuki T; Moritoh K; Akimoto H; Iizuka K; Sato H; Asano K; Yoneda M; Kai C
Sci Rep; 2023 Oct; 13(1):18168. PubMed ID: 37875555
[TBL] [Abstract][Full Text] [Related]
18. Two Sides of The Same Coin: Normal and Tumoral Stem Cells, The Relevance of In Vitro Models and Therapeutic Approaches: The Experience with Zika Virus in Nervous System Development and Glioblastoma Treatment.
Tinnirello R; Chinnici CM; Miceli V; Busà R; Bulati M; Gallo A; Zito G; Conaldi PG; Iannolo G
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686355
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
